Cargando…
用于治疗非小细胞肺癌的阿法替尼脂质体的制备与包封率的测定
BACKGROUND AND OBJECTIVE: Afatinib, a second-generation irreversible epidermal growth factor inhibitor receptor for the development of non-small cell lung cancer and secondary drug resistance, has low bioavailability and adverse reactions due to current oral administration. The aim of this study was...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136998/ https://www.ncbi.nlm.nih.gov/pubmed/30201064 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.09.02 |